Daiken Medical Income Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	10,167	9,951	9,750	9,137	8,540	7,861
Revenue Growth (YoY)	1.57%	2.06%	6.71%	6.99%	8.64%	-7.77%
Cost of Revenue	6,223	5,855	5,768	5,607	4,856	4,503
Gross Profit	3,944	4,096	3,982	3,530	3,684	3,358
Selling, General & Admin	2,632	2,209	2,240	2,105	2,092	1,943
Research & Development	-	332	249	316	382	448
Operating Expenses	2,632	2,584	2,539	2,475	2,533	2,437
Operating Income	1,312	1,512	1,443	1,055	1,151	921
Interest Expense	-11.07	-9	-4	-3	-3	-3
Currency Exchange Gain (Loss)	2.96	-	2	-	1	-
Other Non Operating Income (Expenses)	6.64	6	5	-	3	38
EBT Excluding Unusual Items	1,311	1,509	1,446	1,052	1,152	956
Gain (Loss) on Sale of Assets	-	-	2	-	-	-
Asset Writedown	-6.08	-2	-5	-28	-1	-
Other Unusual Items	1.02	-	-8	-	-	-12
Pretax Income	1,305	1,507	1,435	1,024	1,151	944
Income Tax Expense	323.62	410	447	312	320	269
Net Income	981.12	1,097	988	712	831	675
Net Income to Common	981.12	1,097	988	712	831	675
Net Income Growth	-7.19%	11.03%	38.76%	-14.32%	23.11%	-21.42%
Shares Outstanding (Basic)	29	29	29	29	29	29
Shares Outstanding (Diluted)	29	29	29	29	29	29
EPS (Basic)	34.15	38.19	34.39	24.78	28.93	23.50
EPS (Diluted)	34.15	38.19	34.39	24.78	28.93	23.50
EPS Growth	-7.19%	11.03%	38.76%	-14.32%	23.11%	-21.42%
Free Cash Flow	-	954	1,393	791	931	300
Free Cash Flow Per Share	-	33.21	48.49	27.53	32.41	10.44
Gross Margin	38.79%	41.16%	40.84%	38.63%	43.14%	42.72%
Operating Margin	12.90%	15.19%	14.80%	11.55%	13.48%	11.72%
Profit Margin	9.65%	11.02%	10.13%	7.79%	9.73%	8.59%
Free Cash Flow Margin	-	9.59%	14.29%	8.66%	10.90%	3.82%
EBITDA	-	1,744	1,657	1,322	1,465	1,177
EBITDA Margin	-	17.53%	16.99%	14.47%	17.15%	14.97%
D&A For EBITDA	245.5	232	214	267	314	256
EBIT	1,312	1,512	1,443	1,055	1,151	921
EBIT Margin	12.90%	15.19%	14.80%	11.55%	13.48%	11.72%
Effective Tax Rate	24.80%	27.21%	31.15%	30.47%	27.80%	28.50%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.